Phase 2 Hematologic Disease Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

Hematologic Disease and DisordersHematopoietic Cell Transplant

Northside Hospital, Inc.20 enrolled1 locationNCT06828796

Recruiting

Phase 1Phase 2

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

NeoplasmsHematologic Diseases

Zhejiang University30 enrolled1 locationNCT05827835